InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Schaub James, Executive. Insider active across 3 companies, notably Osmotica Pharmaceuticals plc. Aggregated, 7 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €317k. Activity tracked since 18 May 2021. The latest transaction was filed on 18 May 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Schaub James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,577 shares@ US$0.871.7% of flowOrdinary SharesSEC:0001104659-23-063324:0
9,608 shares@ US$1.264.1% of flowOrdinary SharesSEC:0001104659-23-007068:0
150,000 shares@ US$1.5584.1% of flowOrdinary SharesSEC:0001104659-22-088038:0
Canonical exit: 6 Nov 2022 (T+90)
6,273 shares@ US$1.4030.5% of flowOrdinary SharesSEC:0001104659-22-063391:0
9,607 shares@ US$1.133.7% of flowOrdinary SharesSEC:0001104659-22-007838:0
93,800 shares@ US$1.0784.0% of flowOrdinary SharesSEC:0001104659-21-151769:0
Canonical exit: 16 Mar 2022 (T+90)
6,621 shares@ US$3.1216.0% of flowOrdinary SharesSEC:0001104659-21-069884:0
7 of 7 declarations
About Schaub James
James Schaub is the Executive Vice President and Chief Operating Officer at Osmotica Pharmaceuticals plc. In this role, he oversees the strategic operations and overall direction of the company. Schaub brings valuable expertise in operations management, contributing to optimizing Osmotica's performance. His leadership is essential for achieving the company's operational objectives.
